My research group focuses on leveraging advanced computational technologies to design cyclic peptides and proteins with tailored functions. Our specific aims are: (1) utilizing AI and computational methods to identify and develop novel cyclic peptide drug leads, and (2) applying AI-driven techniques in enzyme engineering and the de novo design of enzymes with desired catalytic properties.